BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 7555555)

  • 1. The influence of pregnancy on IDDM complications.
    Hemachandra A; Ellis D; Lloyd CE; Orchard TJ
    Diabetes Care; 1995 Jul; 18(7):950-4. PubMed ID: 7555555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of complications in insulin-dependent diabetes mellitus: a survival analysis.
    Lloyd CE; Becker D; Ellis D; Orchard TJ
    Am J Epidemiol; 1996 Mar; 143(5):431-41. PubMed ID: 8610658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
    Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy does not induce or worsen retinal and peripheral nerve dysfunction in insulin-dependent diabetic women.
    Lapolla A; Cardone C; Negrin P; Midena E; Marini S; Gardellin C; Bruttomesso D; Fedele D
    J Diabetes Complications; 1998; 12(2):74-80. PubMed ID: 9559484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort.
    Maser RE; Usher D; Becker DJ; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 May; 16(5):755-8. PubMed ID: 8495616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic diabetic complications in patients with MODY3 diabetes.
    Isomaa B; Henricsson M; Lehto M; Forsblom C; Karanko S; Sarelin L; Häggblom M; Groop L
    Diabetologia; 1998 Apr; 41(4):467-73. PubMed ID: 9562352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence and severity of microvascular complications in pancreatic diabetes and IDDM.
    Levitt NS; Adams G; Salmon J; Marks IN; Musson G; Swanepoel C; Levy M; Byrne MJ
    Diabetes Care; 1995 Jul; 18(7):971-4. PubMed ID: 7555558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study.
    Orchard TJ; Forrest KY; Kuller LH; Becker DJ;
    Diabetes Care; 2001 Jun; 24(6):1053-9. PubMed ID: 11375370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I.
    Orchard TJ; Dorman JS; Maser RE; Becker DJ; Ellis D; LaPorte RE; Kuller LH; Wolfson SK; Drash AL
    Diabetes Care; 1990 Jul; 13(7):741-7. PubMed ID: 2387194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular complications in young Asian Indian patients with type 1 diabetes mellitus.
    Ramachandran A; Snehalatha C; Sasikala R; Satyavani K; Vijay V
    Diabetes Res Clin Pract; 2000 Apr; 48(1):51-6. PubMed ID: 10704700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland.
    Ebeling P; Koivisto VA
    Acta Diabetol; 1997 Mar; 34(1):33-8. PubMed ID: 9134055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased prevalence of proliferative retinopathy and cardiovascular autonomic dysfunction in IDDM patients with proteinuria.
    Zander E; Seidlein I; Herfurth S; Heinke P; Chlup R; Badendick K; Strese J; Zander G; Schulz B
    Exp Clin Endocrinol; 1992; 99(2):102-7. PubMed ID: 1639116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group.
    Diabetes Control and Complications Trial Research Group
    Diabetes Care; 2000 Aug; 23(8):1084-91. PubMed ID: 10937502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relations between diabetic retinopathy and cardiovascular neuropathy--a cross-sectional study in IDDM and NIDDM patients.
    Zander E; Heinke P; Herfurth S; Reindel J; Ostermann FE; Kerner W
    Exp Clin Endocrinol Diabetes; 1997; 105(6):319-26. PubMed ID: 9439926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinopathy as a predictor of other diabetic complications.
    El-Asrar AM; Al-Rubeaan KA; Al-Amro SA; Moharram OA; Kangave D
    Int Ophthalmol; 2001; 24(1):1-11. PubMed ID: 11998880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous whole blood platelet aggregation, hematological variables and complications in insulin-dependent diabetes mellitus: the Pittsburgh Epidemiology of Diabetes Complications Study.
    Cho NH; Becker DJ; Ellis D; Kuller LH; Drash AL; Orchard TJ
    J Diabetes Complications; 1992; 6(1):12-8. PubMed ID: 1562753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with diabetic microangiopathy: a study of 157 type I (insulin-dependent) diabetic patients.
    Billault BM; Passa PL
    J Diabet Complications; 1991; 5(4):238-43. PubMed ID: 1779019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II.
    Orchard TJ; Dorman JS; Maser RE; Becker DJ; Drash AL; Ellis D; LaPorte RE; Kuller LH
    Diabetes; 1990 Sep; 39(9):1116-24. PubMed ID: 2384191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limited joint mobility is associated with the presence but does not predict the development of microvascular complications in type 1 diabetes.
    Arkkila PE; Kantola IM; Viikari JS; Rönnemaa T; Vähätalo MA
    Diabet Med; 1996 Sep; 13(9):828-33. PubMed ID: 8891458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.